Bernadette Connaughton
Director · 6 filings · Latest: Aug 10, 2026
Editas Medicine, Inc.
HALOZYME THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
HALO | Bernadette Connaughton | Director | Aug 10, 2026 | Sale | $102.80 | 1,626 | $167.2K | 40,418 | |
HALO | BERNADETTE CONNAUGHTON | — | Aug 10, 2026 | Proposed Sale | $103.12 | 1,626 | $167.7K | — | |
HALO | Bernadette Connaughton | Director | Jul 1, 2026 | Sale | $76.71 | 1,625 | $124.7K | 42,044 | |
HALO | Bernadette Connaughton | Director | Jun 1, 2026 | Sale | $66.21 | 1,625 | $107.6K | 43,669 | |
HALO | Bernadette Connaughton | Director | May 1, 2026 | Sale | $63.48 | 1,625 | $103.2K | 38,498 | |
HALO | BERNADETTE CONNAUGHTON | — | May 1, 2026 | Proposed Sale | $63.66 | 4,875 | $310.3K | — | |
HALO | BERNADETTE CONNAUGHTON | — | Jan 5, 2026 | Proposed Sale | $70.31 | 2,000 | $140.6K | — | |
HALO | BERNADETTE CONNAUGHTON | — | Sep 2, 2025 | Proposed Sale | $73.15 | 8,829 | $645.8K | — |